High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination

Published Date: 10 Jan 2025

ORR of 80% at recommended dose of talquetamab, teclistamab but with high rates of grade 3/4 AEs

Read Full News

Latest News

ASTRO: American Society for Radiation Oncology

A Surgical First for Removal of an Appendiceal Neoplasm

Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches

What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?

Cardiomyopathy risks interrupting cancer treatment, worsening prognosis

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

— News, features, and commentary about cancer-related issues

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

Todays Updates

Rare Tumor in a Rare Location in Patient With Constipation

Could occupational exposure to sawdust explain this case?

Todays Updates

Rare Tumor in a Rare Location in Patient With Constipation

Could occupational exposure to sawdust explain this case?

Latest News

Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches

Cardiomyopathy risks interrupting cancer treatment, worsening prognosis

— News, features, and commentary about cancer-related issues

Case shows importance of accurate preop diagnosis

Some panelists had reservations about the test's true benefit, however

News All Time

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Study Warns on Venetoclax in Double-Hit Lymphoma

Excess deaths seen in trial combining the BCL2 inhibitor with intensive initial regimen

Cancer Diagnosis, Then a Stroke; 9/11 Cancer Deaths; 'Grand Slam' Drug and Price

News, features, and commentary about cancer-related issues

Local Consolidative Therapy After Dual Immunotherapy Fizzles in Metastatic NSCLC

Overall survival favored nivolumab-ipilimumab alone in LONESTAR trial

Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer

Death risk cut by 54% with B7-H3-targeting tambotatug pelitecan and risvutatug rezetecan

No Survival Bump in Metastatic NSCLC With Addition of ADC to Immunotherapy

Non-significant 4-month PFS increase with sacituzumab govitecan-pembrolizumab, no OS benefit

Cancer Drug Shortages Continue With No Immediate Path Toward Relief

All responding NCCN members reported shortages, priorities identified but solutions still needed

Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer

Omitting prophylactic cranial irradiation led to improved cognitive failure-free survival

Nurse Accused of Exorcism; Death After 8 Hours of Plastic Surgery; Top Cancer Months

Health news and commentary gathered by MedPage Today staff

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

Bispecific antibody and ADC together impress in early study

Unprecedented PFS in HER2-Mutant Lung Cancer, but With a Touch of Controversy

Practice-changing median of 14.3 months with T-DXd, but caution over early unfavorable OS trend

Novel Drug Cuts Risk for Death by 44% in Squamous Lung Cancer Trial

If approved, immunotherapy gotistobart could offer a chemo-free option in second-line setting

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

Early efficacy among the highest seen in lung cancer, expert says

Woman Develops Tiny Blood Spots on Her Body After COVID Shot

Case highlights need for quick diagnosis and management of rare disorder

Recommended News For You

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

Will a Mindfulness-Based Treatment for Depression Increase Recovery Rates?

High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination

When does a melanoma metastasize? Implications for management

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image

Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

Recommended Articles For You

Drug Safety Monitoring of Delayed Hematologic Effects After Prolonged Medication Exposure 

Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership 

Oncology in High-Risk Populations: Prevention, Screening and Early Detection in Hereditary and Sex-Specific Cancers 

A Closer Look at the Effects of Sickle Cell on Eyesight 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Why breast cancer survivors don't take their medicine, and what can be done about it.

2.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

3.

Never in a million years did I think I'd have to limit my chemotherapy.

4.

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

5.

Recently released national data on drug use and abuse among Americans.

1.

Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer

2.

Evidence-Based Approaches in Hematology for Modern Medicine

3.

Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer

4.

Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology

5.

Connected Cancer Survivorship Platforms: Transforming Post-Treatment Care Through Digital Integration

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

2.

Updates on Standard V/S High Risk Myeloma Treatment

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

4.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot